FDA Approves Rucaparib for Recurrent Ovarian, Fallopian Tube, Peritoneal Cancer
CMS Begins Mailing Out New Medicare Cards
ASTRO Updates Guideline for Palliative Lung Radiation
CMS Issues Final Rule on CY2019 Policy Changes and Updates to MA, Part D
FDA Approves Blinatumomab for B-Cell Precursor ALL with MRD
CMS Extends MIPS 2017 Data Submission Deadline to April 3
FDA Approves Nilotinib for Pediatric CML
USPSTF Issues Recommendation on Skin Cancer Prevention
CMS's OCM Team to Host May 3 Public Forum
FDA Approves Adcetris Combined with Chemotherapy for First-Line Treatment of Stage III or IV Classical Hodgkin Lymphoma
President's Cancer Panel Urges Collaboration to Better Align Drug Prices with Value
ASTRO Issues Clinical Guideline for WBRT
Trump Administration Announces MyHealthEData Initiative
FDA Authorizes First Direct-to-Consumer Test For 3 BRCA Mutations
FDA Approves Abemaciclib for HR+/HER2- Advanced Breast Cancer
FDA Approves Durvalumab for Stage III Unresectable NSCLC
FDA Approves Erleada for Certain Prostate Cancer Patients
ASCO & NCCN Release Guidance on Management of Immunotherapy Side Effects
Proceedings from NASEM Workshop on Weight Management & Exercise Across Cancer Continuum Available
White House Issues Report on Reforming Drug Pricing
CMS to Host 2017 MIPS Submission Q & A Sessions
MIPS Reporting Deadlines Coming Soon
FDA Approves Zytiga Plus Prednisone for Metastatic High-Risk Prostate Cancer
ASCO Reviews Commercial Clinical Pathways Landscape
FDA Approves New Treatment for Certain Digestive Tract Cancers
Alex Azar to Head HHS
CAP, IASLC, AMP Release Updated Lung Biomarker Guideline
MAC Operations To Continue During Government Shutdown
MedPAC Recommends Eliminating MIPS
FDA Approves Olaparib for Germline BRCA-mutated Metastatic Breast Cancer
